P/E společnosti Nymox Pharmaceutical Corp
Jaká je hodnota metriky P/E společnosti Nymox Pharmaceutical Corp?
Hodnota metriky P/E společnosti Nymox Pharmaceutical Corp je 0.00
Jaká je definice metriky P/E?
P/E ratio je koeficient daný poměrem ceny akcie a příjmu společnosti na akcii za posledních 12 měsíců.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Nymox Pharmaceutical Corp
Čemu se věnuje společnost Nymox Pharmaceutical Corp?
nymox pharmaceutical corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. its lead drug candidate is fexapotide triflutate (nx-1207) that has completed phase iii clinical trials for the treatment of benign prostatic hyperplasia; and is in phase ii clinical trial for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. the company also develops and markets nicalert and tobacalert test strips that use urine or saliva to detect use of tobacco products. in addition, it offers alzheimalert, a proprietary urine assay that aids physicians in the diagnosis of alzheimer's disease. the company operates in canada, the united states, europe, and internationally. nymox pharmaceutical corporation was founded in 1989 and is headquartered in nassau, bahamas.
Firmy s metrikou p/e podobnou společnosti Nymox Pharmaceutical Corp
- Hodnota metriky P/E společnosti Richland Resources International je N/A
- Hodnota metriky P/E společnosti Safeplus International je N/A
- Hodnota metriky P/E společnosti China Yanyuan Yuhui Natl Ed Grp je N/A
- Hodnota metriky P/E společnosti Acusphere je N/A
- Hodnota metriky P/E společnosti American Oriental Bioengineering je N/A
- Hodnota metriky P/E společnosti Gourmet Provisions International je N/A
- Hodnota metriky P/E společnosti Nymox Pharmaceutical Corp je 0.00
- Hodnota metriky P/E společnosti SEL Manufacturing je 0.00
- Hodnota metriky P/E společnosti China Zhong Qi Hldgs je 0.00
- Hodnota metriky P/E společnosti MedSmart je 0.00
- Hodnota metriky P/E společnosti Panbela Therapeutics je 0.00
- Hodnota metriky P/E společnosti Epic je 0.00
- Hodnota metriky P/E společnosti 2574 je 0.00